Menu

Day: June 19, 2019

2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice.
Source…

Childhood Vaccine Assessment Tool

Source: Centers for Disease Control and PreventionRelated MedlinePlus Pages: Childhood ImmunizationSource…

Slide show: The Mediterranean diet

Source…